Volume 22 Supplement 1
Pre-hospital resuscitative endovascular balloon occlusion of the aorta
© Andersen et al; licensee BioMed Central Ltd. 2014
Published: 7 July 2014
Internal bleeding from pelvic fractures is difficult to stop with external compression and necessitates other resuscitation techniques such as endovascular balloon occlusion of the aorta (REBOA). This minimally invasive procedure stops the bleeding by inflating a balloon in the aorta, and has been used successfully in emergency departments and operations theaters. If REBOA also is feasible in the pre-hospital environment is unknown.
To present two supplementary training methods for REBOA; A gelatin model for repetitive exercise of technical skills and a porcine model for “live-tissue” training and evaluation of the hemodynamic effects of the aortic occlusion.
A gelatin-mannequin, containing water filled bicycle tubes to mimic the aorta and femoral arteries, was casted. A doctor-paramedic crew performed the REBOA procedure three times in a realistic pre-hospital environment. The time from arrival to balloon-inflation and skin contact to balloon-inflation was recorded.
A porcine model (blood volume 3640 mL) was bled (200 mL of blood withdrawn) in eight consecutive steps to a total blood loss of 44%. The balloon was inserted through the femoral artery and into the aorta using an ultrasound guided Seldinger-technique, and inflated and deflated after each bleeding step. The systolic (SBP) and diastolic (DBP) blood pressures were measured.
REBOA could stop pelvic bleedings and improve central perfusion during massive bleeding. The technique appears feasible in the pre-hospital environment with an insertion time approximating 3 minutes after training. To treat the right patients at the right time requires additional decision-making skills for pre-hospital crews.
Conflict of interest
The authors state no conflicts of interest.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.